Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2002;91:553-555
doi: 10.1161/01.RES.0000036862.37203.F4
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pieske, B.
Right arrow Articles by Kockskämper, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pieske, B.
Right arrow Articles by Kockskämper, J.
Related Collections
Right arrow Calcium cycling/excitation-contraction coupling
(Circulation Research. 2002;91:553.)
© 2002 American Heart Association, Inc.


Editorials

Alternans Goes Subcellular

A "Disease" of the Ryanodine Receptor?

Burkert Pieske, Jens Kockskämper

From the Department of Cardiology and Pneumology, University of Göttingen, Germany.

Correspondence to Priv-Doz Dr Burkert Pieske, Dept of Cardiology and Pneumology, University of Göttingen, Robert-Koch-Str 40, 37075 Göttingen, Germany. E-mail pieske@med.uni-goettingen.de


Key Words: alternans • ventricular fibrillation • ryanodine receptor


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

In 1872 Traube1 first described pulsus alternans, a regular beat-to-beat alternation of the strength of the heartbeat. Since then, cardiologists and physiologists have learned that cardiac alternans can come in many flavors: as mechanical, electrical, or [Ca2+]i transient alternans (Ca2+ alternans).2 They also had to realize that alternans is a life-threatening condition, less so because of impaired cardiac output but because it can lead to ventricular fibrillation (VF) and sudden cardiac death. How exactly electromechanical alternations of the heartbeat can cause VF has long been an open question. A leap forward came recently with an elegant study on electrical (T-wave) alternans in guinea-pig hearts.3 It was shown that during alternans, neighboring regions within the heart started to alternate out-of-phase with each other (discordant alternans). Such discordant electrical alternans, if sufficient in magnitude, led to unidirectional block and reentry, thereby causing VF.

Ca2+ Alternans: The Heart of the Problem

Despite recent advances in our understanding of the mechanisms linking electromechanical alternans to VF, the crucial question still remains: how does alternans develop in the first place? The study of cellular Ca2+ alternans might help answer this question because Ca2+ alternans lies at the heart of the problem. It causes both mechanical alternans (by activation of the myofilaments) and electrical alternans (by modulation of Ca2+-dependent membrane currents). Experimental interventions aimed at disabling sarcoplasmic reticulum (SR) Ca2+ release abolish electromechanical alternans.4 Furthermore, enhancement of sarcolemmal Ca2+ influx and/or SR Ca2+ load and release can reverse alternans.5,6 Thus, modulation of the SR Ca2+ release process is somehow critically involved . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Jiang, W. Chen, R. Wang, L. Zhang, and S. R. W. Chen
Loss of luminal Ca2+ activation in the cardiac ryanodine receptor is associated with ventricular fibrillation and sudden death
PNAS, November 13, 2007; 104(46): 18309 - 18314.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. R. Sipido
Understanding Cardiac Alternans: The Answer Lies in the Ca2+ Store
Circ. Res., March 19, 2004; 94(5): 570 - 572.
[Full Text] [PDF]


Home page
Circ. Res.Home page
M. C. Sanguinetti and P. B. Bennett
Antiarrhythmic Drug Target Choices and Screening
Circ. Res., September 19, 2003; 93(6): 491 - 499.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. V Zima, J. Kockskamper, R. Mejia-Alvarez, and L. A Blatter
Pyruvate Modulates Cardiac Sarcoplasmic Reticulum Ca2+ Release in Rats Via Mitochondria-Dependent and -Independent Mechanisms
J. Physiol., August 1, 2003; 550(3): 765 - 783.
[Abstract] [Full Text] [PDF]